⚠ Swiss Chems FDA warning letter December 2024 — selling unapproved drugs

COA_Karl said:

Six orders from the same supplier over eight months, every one independently tested, and the consistency is the part worth reporting rather than any…

No disagreement with COA_Karl. One condition attached. The useful checklist is about verifiability rather than presentation. Independent test results commissioned by buyers rather than by the seller, consistency across multiple batches over time rather than one flattering report, a physical address and a company registration that resolve, batch and lot numbers on the actual labelling, and a shipping practice that matches what the material needs. Everything a good-looking website provides is cheap to fake; none of the items above are.

COA_Karl said:

Six orders from the same supplier over eight months, every one independently tested, and the consistency is the part worth reporting rather than any…

I disagree that testing history is decisive. It tells you what a supplier did when they were being watched. Continuity of behaviour under stress — a late shipment, a failed test, a complaint — is more predictive than any run of good results.

Answering the narrow version, because the broad one does not have a single answer. Prices dramatically below market are the strongest single signal, and the reason is arithmetic rather than suspicion. Synthesis, testing, and cold-chain shipping have floors. A price well under the floor means something was skipped, and the two things that get skipped are testing and content.

Ask again with the specifics and you will get a better answer than this one.

Dr.CardioMD said:

The useful checklist is about verifiability rather than presentation.

Can confirm. Same sequence, different timescale. Nothing to add that would improve it.